expert roundtables

Treatment Progression and FDA-Approved Second-Line Therapy
Oncology

Treatment Progression and FDA-Approved Second-Line Therapy

expert roundtables
By Alok Khorana, MD; Michael Morse, MD, MHS, FACP; Thomas A. Abrams, MD
Treatment Approaches to Relapsing-Remitting Multiple Sclerosis
Neurology

Treatment Approaches to Relapsing-Remitting Multiple Sclerosis

expert roundtables
By David A. Hafler, MD; Dean Wingerchuk, MD, FRCP(C), MSc; Staley Brod, MD
The Clinical Challenges of Slowing Disability Progression in Patients With Primary Progressive Multiple Sclerosis
Neurology

The Clinical Challenges of Slowing Disability Progression in Patients With Primary Progressive Multiple Sclerosis

expert roundtables
By David A. Hafler, MD; Dean Wingerchuk, MD, FRCP(C), MSc; Staley Brod, MD
The Need for Effective Therapies for Relapsing-Remitting Multiple Sclerosis and Primary Progressive Multiple Sclerosis
Neurology

The Need for Effective Therapies for Relapsing-Remitting Multiple Sclerosis and Primary Progressive Multiple Sclerosis

expert roundtables
By David A. Hafler, MD; Dean Wingerchuk, MD, FRCP(C), MSc; Staley Brod, MD
Treatment Strategies for Reducing Active Symptoms and Delaying Disability in Patients With Multiple Sclerosis
Neurology

Treatment Strategies for Reducing Active Symptoms and Delaying Disability in Patients With Multiple Sclerosis

expert roundtables
By David A. Hafler, MD; Dean Wingerchuk, MD, FRCP(C), MSc; Staley Brod, MD
Load More